Arterial Remodeling Technologies is healthcare firm that designs and develops bioresorbable peripheral and coronary polymer stents... Read more
Art Stent CEO: Machiel Van Der Leest

CEO

Machiel Van Der Leest

CEO Approval Rating

68/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
Funding
$8.5M

Art Stent Competitors

1Amaranth Medical
2Neotherix
3Kuros Biosciences AG
4Elixir
5Terumo Medical

Trending Companies